Adalimumab for Crohn's disease: Long-term sustained benefit in a population-based cohort of 438 patients

C.P. Peters, E.J. Eshuis, F.M. Toxopeus, M.E. Hellemons, J.M. Jansen, G.R.A.M. D'Haens, P. Fockens, P.C.F. Stokkers, H.A.R.E. Tuynman, A.A. van Bodegraven, C.Y. Ponsioen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)866-875
JournalJournal of Crohn's and Colitis
Issue number8
Publication statusPublished - 2014

Cite this